Clinical Significance of ARID1A and ANXA1 in HER-2 Positive Breast Cancer.

Rita Silva-OliveiraFilipa Ferreira PereiraSara PetronilhoAna Teresa MartinsAna LameirinhasVera ConstâncioInês Caldas-Ribeiro Sofia SaltaPaula LopesLuís AntunesFernando CastroSusana Palma de SousaRui M Henrique Carmen Jerónimo

Published in: Journal of clinical medicine (2020)

overall, our results suggest that ANXA1 may be a useful prognostic marker in HER-2+ patients. Additionally, its ability to discriminate between HER-2+ (non-luminal) and luminal B-like (HER-2+) patients might assist in patient stratification regarding treatment strategy.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
positive breast cancer
prognostic factors
peritoneal dialysis
case report